Mary Ann Son

Papers

Total Citations

H-Index

About

Dr. Mary Ann Son is a pioneering gynecologic surgeon whose work focuses on advancing minimally invasive techniques for complex obstetric and gynecologic conditions. Her most notable contribution is the first reported elective robotic hysterectomy for placenta accreta spectrum (PAS) in the second trimester, a groundbreaking procedure that offers a fertility-sparing alternative for women with this life-threatening condition. This landmark 2020 case report, cited 6 times, demonstrates her innovative approach to managing PAS through robotic surgery with pregnancy in situ. Dr. Son has also made significant contributions to postoperative pain management, leading a randomized double-blinded placebo-controlled trial (2022) evaluating liposomal bupivacaine injections for analgesia during minimally invasive supracervical hysterectomy. Her research directly addresses two critical challenges in women's health: reducing surgical morbidity in high-risk pregnancies and improving recovery after routine gynecologic procedures. With a focus on evidence-based practice, Dr. Son's work bridges the gap between surgical innovation and patient-centered outcomes, establishing her as a leader in minimally invasive gynecologic surgery and a valuable resource for clinicians seeking to expand the boundaries of what is possible in the operating room.